Dyslipidemia Flashcards
ASCVD, primary and secondary HLD, natural products, statins and add ons, key counseling points (36 cards)
non HDL cholesterol goal
<130
LDL goal no ASCVD or DM
<100
HDL goal
> 40 men
50 women
TG goal
<150
LDL equation
LDL = TC - HDL - TG/5
ASCVD events
MI, stroke/TIA, stable angina, PAD
what medications increase LDL only
fibrates
non-Vascepa fish oils
what medications increase TG only
IV lipids
propofol
clevidipine
BAS
what medications increase both LDL and TG
diuretics
efavirenz
CYA
tacro
atypical APs
protease-i
when should a statin always be started
DM
clinical ASCVD secondary prevention
LDL 190+
patient 63yo male with a PMH significant for MI, t2DM x3 years
What intensity statin should they be on?
What is the LDL goal?
diabetics with ASCVD hx should always be put on a high intensity statin
LDL goal is <55 due to ASCVD event and risk
patient 69yo female a PMH of OP, RA, gout and depression. LDL 195
What intensity statin should they be on?
What is the LDL goal
high, all patients with an LDL 190+ should be placed on high intensity statin regardless of ASCVD or DM status
LDL goal is <100
LDL goals
no ASCVD +/- DM–> <70
ASCVD or high risk –> <55
no ASCVD or DM –> <100
moderate intensity statins
rosuvastatin 5-10
atorvastatin 10-20
simvastatin 20-40
lovastatin 40
pravastatin 40-80
fluvastatin 80
moderate intensity statins
rosuvastatin 5-10
atorvastatin 10-20
simvastatin 20-40
lovastatin 40
pravastatin 40-80
fluvastatin 80
moderate intensity statins
rosuvastatin 5-10
atorvastatin 10-20
simvastatin 20-40
lovastatin 40
pravastatin 40-80
fluvastatin 80
high intensity statins
rosuvastatin 20-40
atorvastatin 40-80
how should a lipid panel be monitored in dyslipidemia
q4-12 weeks after initiation or dose change then yearly thereafter
which are the hydrophilic statins
rosuvastatin
pravastatin
what medications inhibit statin metabolism via 3A4
G PACMAN
grapefruit
protease-i
azole antifungals
cya, cisplatin
macrolides (erythro, clarithro)
amiodarone
non-DHP CCB (dilt, verap)
when do we initiate add on treatment to statins
when the patient is on a maximally tolerated statin
zetia
avoid in …
dosing
LDL lowering %?
avoid in pregnancy, breast feeding, liver disease
10mg po qd
dec LDL 18-23%
PCSK9i
medications in class (brand and generic)
LDL and HDL lowering expected
alirocumab (Praluent)
evolocumab (Repatha)
dec LDL ~60%
dec HDL ~36%
which drugs are the BAS?
effects on lipids?
CI?
colesevelam (Welchol)
cholestyramine
dec LDL 10-30%, inc TG 5%
CI in TG >500, bowel obstruction, inc TG 2/2 pancreatitis